News in brief
Arctic clouds and harnessing light: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
Arctic clouds and harnessing light: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
AMS professorship and disease relapse: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
Audio
Podcast: HIV tests, infectious reading, and the fight for cheaper drugs
In this edition: A new test to monitor treatment-resistant HIV, a book tracing the fight against infection, and how the NHS can make cheaper drugs.
Feature
A life in paediatric HIV research and care: Prof Gareth Tudor-Williams retires
Professor Gareth Tudor-Williams has retired after a career spanning over three decades in paediatric HIV research and care.
First major study of new HIV therapy opens to recruitment
The RIO clinical trial will test whether a new type of therapy can keep HIV under control without daily antiretroviral treatment (ART) tablets.
Universal ‘Test and Treat’ for HIV cost-effective in high prevalence regions
Rolling out home-based testing and universal treatment for HIV is cost-effective and can cut the incidence of cases in high-prevalence communities.
COVID-19 disruptions to HIV prevention could increase new infections amongst men
Disruptions to HIV prevention and treatment strategies due to the pandemic could increase new HIV infections amongst men who have sex with men.
Potential therapeutic targets for cancer-causing virus uncovered by new research
Scientists have discovered key factors that control the genome maintenance and replication of a virus responsible for a rare form of cancer.
Video
COVID-19 pandemic could significantly increase HIV, TB and malaria cases
Some regions may see deaths related to HIV, TB and malaria increase by up to 10, 20 and 36% respectively over five years due to the COVID-19 pandemic.
1
Video
The search for an HIV vaccine: Professor Jonathan Weber reflects on his career
From its emergence in the 1980s to setting up multi-national vaccine trials, Prof Jonathan Weber reflects on his career spent researching HIV/AIDS.